In the context of the strategic importance of pharmaceutical industry, Egypt establishes “Gyptophrama”, the largest integrated structure for pharmaceutical industry in Africa and Middle East, which was established in accordance with the latest scientific methods and techniques to empower Egypt to achieve medicines security & overcome any monopolistic practices in crises through providing a secure & effective medicine. It also helps Egypt to increase exports and attract more investments, and hence Egypt will become a regional and global centre for pharmaceutical industry.
“Gyptopharma” is an integrated city for pharmaceutical industry, located in Khanka- Al- Qalubiyah, over an area of 180.000 m2. 10.000 m2 of this area have been allocated to establish a power station with a capacity of up to 50 MVA for providing electricity to the project. The area includes research, development, & quality assurance laboratories, reference samples storage, and moving archive store as well.
As to the project`s production capacity, it is up to 100 million package a year for 150 kinds of medicine during the first phase of the project, which was inaugurated in April,2021 over an area of 120.000 m2 with 15 production lines, 7000 m2 for storage, and 5 buildings for industrial services, besides the medicine factories.